Get the Stockscreener App
31.38
0.45%
0.14
After Hours:
31.38
Enovis Corp stock is traded at $31.38, with a volume of 824.77K.
It is up +0.45% in the last 24 hours and down -2.00% over the past month.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
See More
Previous Close:
$31.24
Open:
$31.14
24h Volume:
824.77K
Relative Volume:
0.94
Market Cap:
$1.79B
Revenue:
$2.19B
Net Income/Loss:
$-829.17M
P/E Ratio:
-2.2021
EPS:
-14.25
Net Cash Flow:
$-3.95M
1W Performance:
-4.50%
1M Performance:
-2.00%
6M Performance:
-11.10%
1Y Performance:
-26.04%
1-Day Range:
$30.68
$31.46
1-Week Range:
$29.75
$33.13
52-Week Range:
$25.46
$49.83
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
31.38 | 1.79B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
How Enovis Corporation stock compares to growth peersGap Up & Weekly Return Optimization Plans - newser.com
Combining machine learning predictions for Enovis CorporationJuly 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com
Will Enovis Corporation (C520) stock outperform Dow JonesGlobal Markets & Entry Point Confirmation Signals - newser.com
Will Enovis Corporation stock announce a stock splitWeekly Stock Recap & Long-Term Growth Plans - newser.com
How institutional buying supports Enovis Corporation stock2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Is Enovis Corporation stock a defensive play in 2025CEO Change & Weekly Momentum Picks - newser.com
Is Enovis Corporation stock supported by strong fundamentalsJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
Signal strength of Enovis Corporation stock in tech scannersEarnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Enovis Corporation $ENOV Stake Raised by State of New Jersey Common Pension Fund D - MarketBeat
Is Enovis Corporation stock attractive for long term wealth buildingMarket Growth Review & Low Drawdown Investment Ideas - newser.com
Is Enovis Corporation (C520) stock bottoming after sell offTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
Why Enovis Corporation (C520) stock appears on watchlistsPortfolio Performance Summary & Free Long-Term Investment Growth Plans - newser.com
Trend analysis for Enovis Corporation this weekQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
How Enovis Corporation stock reacts to stronger dollar2025 Earnings Impact & Fast Moving Stock Watchlists - newser.com
Market reaction to Enovis Corporation’s recent newsMarket Activity Report & Low Risk Profit Maximizing Plans - newser.com
Is Enovis Corporation stock a top momentum play2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-30 22:49:03 - newser.com
Enovis (ENOV) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
What to expect from Enovis Corporation in the next 30 daysJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Is Enovis Corporation stock vulnerable to rate hikesPortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
Can Enovis Corporation stock test all time highsMarket Weekly Review & Precise Swing Trade Alerts - newser.com
Measuring Enovis Corporation’s beta against major indicesJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Using flow based indicators on Enovis CorporationAnalyst Downgrade & Community Consensus Stock Picks - newser.com
Enovis (ENOV): Evaluating Current Valuation After Recent Share Price Momentum - Yahoo Finance
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):